Steven Cohen Amgen Inc Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $58.4 Million - $72.5 Million	267,033 Added 15615.96%	268,743 $72.2 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $366,401 - $433,262	1,710 New	1,710 $379,000
Q3 2019 Nov 15, 2019	SELL	$174.11 - $208.62 $174,110 - $208,620	-1,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $166,700 - $195,410	1,000 New	1,000 $184,000

2,932

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.